The New Zealand Health system is great for the cancer treatments that they do fund, including radiation and chemotherapy. Pharmac the NZ government supplier of medicines funds Keytruda Immunotherapy for Melanoma, but not for any other forms of cancer. Anders’ biopsy test for Keytruda returned a 100 point success rate, where 20 points is enough for Oncologists to go ahead with treatment internationally.
So, Keytruda, a respected and successful immunotherapy drug, is available to Anders at a cost. He will need more than a NZ$100,000 to pay for treatment to extend his life.
Please contribute to his lifesaving Keytruda Immunotherapy costs.
Can you help in even a small way?
Anders needs help to fund Immunotherapy treatment which will extend his life span to allow him to enjoy his family and young children as they progress into their young adult lives and beyond.
Anders had neck cancer in 2016, he was treated with radiation and chemotherapy.
Three years later, the cancer has now spread to Anders pelvic bone, lungs, lymph nodes and liver. Radiation on the pelvic bone has successfully halted the ongoing pain.
The first dose of chemotherapy for 2019 resulted in Anders’ hospitalization with life threatening elevated glucose levels and a prolonged extreme heart rate.
The second dose was altered by the Oncologist team and Anders has just got through it. His Oncologist consultant is certain that Anders’ improved quality of life is a sign that the chemotherapy is working. The plan is for nine chemotherapy treatments, each separated by three weeks. As long as Anders has no further extreme reactions to the chemotherapy this half year plan will continue. However, as soon as Anders can no longer cope with the chemotherapy, the treatment will move to Immunotherapy - which we need help to finance.